Answers are grounded in this paper and cite their sources.
Sir, Vitiligo is a common idiopathic acquired disorder of unknown cause, which produces disfiguring white patches of depigmentation. A large variety of therapeutic agents has been tried for its treatment, but no definitive cure is yet available. Topical and systemic steroids have been reported to display variable efficacy in the treatment of vitiligo.1 The most widely used procedure has been phototherapy alone or in combination with topical corticosteroids or pseudocatalase.1–3 One of the most frequently used forms of phototherapy is topical psoralen plus ultraviolet (UV) A (PUVA). However, there is concern over its long‐term effects, especially in children, with regard to the increased risks of carcinogenesis and premature ageing of the skin. l‐Phenylalanine plus UVA treatment has also been reported to lead to a good therapeutic effect in children with extensive vitiligo, but this result was not confirmed by others.4 Narrow‐band UVB (NB–UVB) phototherapy has recently been found to be highly effective and well tolerated in both adults and children.5–7 NB–UVB therapy has been claimed to have fewer adverse effects compared with PUVA therapy. Although insufficient human data are available, it has been calculated that long‐term NB–UVB therapy may involve a lower risk of skin cancer than that of PUVA therapy.8
No takes yet. Share an insight, caveat, or question.
Baltás et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: